Deloitte’s Luc Brucher delves into market integration efforts in Luxembourg, Europe’s ‘test-bed,’ for a new and unique approach to healthcare. Committed to creating innovative medical solutions, Brucher explains why Deloitte are seeking both short and long-term results.
The life sciences sector in Luxembourg represents an emerging and evolving market with significant investments during the last decade. Can you start by giving us a brief historical overview of how Luxembourg has built its life sciences sector?
"To support research and make the country a global leader in incorporating personalized medicine into a national healthcare system, multiple initiatives have been launched."
